Skip to main content
Figure 2 | Journal of Inflammation

Figure 2

From: Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase

Figure 2

Pentoxifylline (PTX, 50 and 100 mg/kg) treatments for 5 days significantly decrease edema volumes in diabetic rats, 48 h after the carrageenan injection. Glibenclamide (GLI, 5 mg/kg) and normal controls (non-diabetic rats) were included for comparisons. The values are means ± SD from 8 to 13 animals. a. vs. diabetic 3 h, q = 9.519; b. vs. diabetic 48 h, q = 11.49; c. vs. diabetic + PTX100, 48 h, q = 5.659; d. vs. diabetic, 48 h, q = 16.47; e. vs. diabetic 48 h, q = 12.90; f. vs. diabetic 48 h, q = 17.54; g. vs. normal 48 h, q = 6.049 (One-way ANOVA ans Tukey’s as the post hoc test).

Back to article page